ADBiotech 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Hong-Geo Jung

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	33.8%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	데이터 없음

최근 관리 업데이트

Recent updates

Here's Why ADBiotech (KOSDAQ:179530) Can Afford Some Debt

Sep 02

CEO

Hong-Geo Jung

no data

테뉴어

Mr. Hong-Geo Jung is Chief Executive Officer of ADBiotech Co., Ltd.

ADBiotech 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

ADBiotech Co., Ltd., Annual General Meeting, Mar 30, 2021

Recent updates

New major risk - Share price stability

Here's Why ADBiotech (KOSDAQ:179530) Can Afford Some Debt

New minor risk - Share price stability

ADBiotech Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd

Full year 2023 earnings released: ₩313 loss per share (vs ₩297 profit in FY 2022)

Investor sentiment improves as stock rises 20%

Investor sentiment deteriorates as stock falls 18%

New major risk - Share price stability

Investor sentiment improves as stock rises 19%

Third quarter 2023 earnings released: ₩104 loss per share (vs ₩29.00 loss in 3Q 2022)

Investor sentiment deteriorates as stock falls 17%

Investor sentiment improves as stock rises 35%

ADBiotech Co., Ltd. (KOSDAQ:A179530) agreed to acquire a 19.36% stake in Wiju Inc. for KRW 1.29 billion.

ADBiotech Co., Ltd. announced that it has received KRW 4.5 billion in funding

ADBiotech Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding

ADBiotech Co., Ltd., Annual General Meeting, Mar 30, 2021

New 90-day high: ₩26,700

New 90-day high: ₩22,950

New 90-day high: ₩20,000

New 90-day high: ₩19,950

New 90-day high: ₩19,000

New 90-day high - ₩16,900

ADBiotech Co., Ltd. announced that it has received KRW 3.0000065 billion in funding from SBI Investment Korea Co., Ltd.

ADBiotech Co., Ltd. announced that it expects to receive KRW 1 billion in funding

ADBiotech Co., Ltd. announced that it expects to receive KRW 3.0000065 billion in funding from SBI Investment Korea Co., Ltd.

CEO

테뉴어